China In Vitro Fertilization Market Size & Outlook
Global Market
Related Markets
China in vitro fertilization market highlights
- The China in vitro fertilization market generated a revenue of USD 2,519.3 million in 2025 and is expected to reach USD 4,244.7 million by 2033.
- The China market is expected to grow at a CAGR of 6.57% from 2026 to 2033.
- In terms of segment, frozen nondonor was the largest revenue generating procedure type in 2025.
- Fresh Donor is the most lucrative procedure type segment registering the fastest growth during the forecast period.
In vitro fertilization market data book summary
| Market revenue in 2025 | USD 2,519.3 million |
| Market revenue in 2033 | USD 4,244.7 million |
| Growth rate | 6.57% (CAGR from 2026 to 2033) |
| Largest segment | Frozen nondonor |
| Fastest growing segment | Fresh Donor |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Fresh Nondonor, Frozen Nondonor, Fresh Donor, Frozen Donor |
| Key market players worldwide | Bayer AG, Cook Medical, Merck KGaA, Ferring, FUJIFILM Holdings Corp, Genea Biomedx, Merck & Co Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife AB ADR, Boston Scientific Corp, Nova IVF, Fortis Healthcare, RMA Network, TFP Fertility Group, US Fertility |
Other key industry trends
- In terms of revenue, China accounted for 8.8% of the global in vitro fertilization market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, Japan in vitro fertilization market is projected to lead the regional market in terms of revenue in 2033.
- Thailand is the fastest growing regional market in Asia Pacific and is projected to reach USD 992.1 million by 2033.
The reduce the single child law is expected to drive market growth, as well as increase the number of people traveling abroad to avail these treatments. China has one of the largest IVF markets globally. The demand for fertility treatments, including IVF, has been increasing due to factors such as delayed marriages, rising infertility rates, and a growing awareness of assisted reproductive technologies.
China currently has 539 public & private IVF facilities, and the National Health Commission (NHC) set a goal to establish one IVF facility for every 2.3 million people in the country by 2025. This ambitious plan would increase the total number of IVF facilities in China to over 600.
The aim of expanding the number of IVF facilities is to improve accessibility to fertility treatments for individuals and couples across the country. By increasing the availability of IVF services, the government of China hopes to address fertility issues, promote reproductive health, and support individuals in their desire to start or expand their families.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
In Vitro Fertilization Market Scope
In Vitro Fertilization Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Boston Scientific Corp | View profile | 48,000 | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 | www.bostonscientific.com |
| Vitrolife AB ADR | View profile | 1,116 | Box 9080, Gothenburg, Sweden, 400 92 | www.vitrolife.com |
| FUJIFILM Holdings Corp | View profile | 83,784 | 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 | www.fujifilmholdings.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Merck & Co Inc | View profile | 72,000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | www.merck.com |
| The Cooper Companies Inc | View profile | 15,000 | 6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, United States, 94583 | www.coopercos.com |
| Genea Biomedx | View profile | 101-250 | Sydney, New South Wales, Australia, Oceania | www.geneabiomedx.com |
| Bayer AG | View profile | 99,723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | www.bayer.com |
| Cook Medical | View profile | 10001+ | Bloomington, Indiana, United States, North America | www.cookmedical.com |
China In Vitro Fertilization Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to In Vitro Fertilization Market Outlook will help companies and investors design strategic landscapes.
Frozen Nondonor was the largest segment with a revenue share of 52.8% in 2025.
Horizon Databook has segmented the China in vitro fertilization market based on fresh nondonor, frozen nondonor, fresh donor, frozen donor covering the revenue growth of each sub-segment from 2021 to 2033.
The reduce the single child law is expected to drive market growth, as well as increase the number of people traveling abroad to avail these treatments. China has one of the largest IVF markets globally. The demand for fertility treatments, including IVF, has been increasing due to factors such as delayed marriages, rising infertility rates, and a growing awareness of assisted reproductive technologies.
China currently has 539 public & private IVF facilities, and the National Health Commission (NHC) set a goal to establish one IVF facility for every 2.3 million people in the country by 2025. This ambitious plan would increase the total number of IVF facilities in China to over 600.
The aim of expanding the number of IVF facilities is to improve accessibility to fertility treatments for individuals and couples across the country. By increasing the availability of IVF services, the government of China hopes to address fertility issues, promote reproductive health, and support individuals in their desire to start or expand their families.
- China In Vitro Fertilization Market Procedure Type Outlook (Revenue, USD Million , 2021-2033)
- Fresh Nondonor
- Frozen Nondonor
- Fresh Donor
- Frozen Donor
- China In Vitro Fertilization Market Providers Outlook (Revenue, USD Million , 2021-2033)
- Fertility Clinics
- Hospitals and Other Settings
Reasons to subscribe to In Vitro Fertilization Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of In Vitro Fertilization Market Outlook databook
- Our clientele includes a mix of In Vitro Fertilization Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China In Vitro Fertilization Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into China In Vitro Fertilization Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
China In Vitro Fertilization Market, 2021-2033 (US$M)
China in vitro fertilization market statistics, by procedure type, 2021-2033 (US$M)
